A Case of Severe Seronegative Inflammatory Arthritis due to Nivolumab and Review of the Literature

Immune-checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer, yet therapy is often hampered by immune-related adverse events (irAEs) which range from mild to severe life-threatening events. Musculoskeletal (MSK) irAEs leading to discontinuation of ICIs are uncommon but increasingl...

Descripción completa

Detalles Bibliográficos
Autores principales: Thapa, Bicky, Ali, Asad, Nair, Raunak, Vashisht, Rishik, Calabrese, Cassandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875374/
https://www.ncbi.nlm.nih.gov/pubmed/31781462
http://dx.doi.org/10.1155/2019/1326734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875374/
https://www.ncbi.nlm.nih.gov/pubmed/31781462
http://dx.doi.org/10.1155/2019/1326734

Ejemplares similares